Published in Pflugers Arch on April 23, 2008
Combination of secretin and fluvastatin ameliorates the polyuria associated with X-linked nephrogenic diabetes insipidus in mice. Kidney Int (2014) 2.08
β3 adrenergic receptor in the kidney may be a new player in sympathetic regulation of renal function. Kidney Int (2016) 1.38
Lithium causes G2 arrest of renal principal cells. J Am Soc Nephrol (2014) 1.26
Aquaporins in kidney pathophysiology. Nat Rev Nephrol (2010) 1.18
Intrarenal angiotensin III infusion induces natriuresis and angiotensin type 2 receptor translocation in Wistar-Kyoto but not in spontaneously hypertensive rats. Hypertension (2008) 1.03
Collecting duct principal cell transport processes and their regulation. Clin J Am Soc Nephrol (2014) 1.02
Arginine-vasopressin V1a receptor inhibition improves neurologic outcomes following an intracerebral hemorrhagic brain injury. Neurochem Int (2011) 1.02
Quantitative phosphoproteomics in nuclei of vasopressin-sensitive renal collecting duct cells. Am J Physiol Cell Physiol (2012) 0.98
Transcription factor CREB3L1 regulates vasopressin gene expression in the rat hypothalamus. J Neurosci (2014) 0.93
Phosphorylation of aquaporin-2 regulates its water permeability. J Biol Chem (2010) 0.92
New insights into the dynamic regulation of water and acid-base balance by renal epithelial cells. Am J Physiol Cell Physiol (2012) 0.92
Reno-endocrinal disorders: A basic understanding of the molecular genetics. Indian J Endocrinol Metab (2012) 0.90
Identification of phosphorylation-dependent binding partners of aquaporin-2 using protein mass spectrometry. J Proteome Res (2009) 0.89
Aquaporin-2 in the "-omics" era. J Biol Chem (2009) 0.87
The lineage-specific evolution of aquaporin gene clusters facilitated tetrapod terrestrial adaptation. PLoS One (2014) 0.86
A knowledge base of vasopressin actions in the kidney. Am J Physiol Renal Physiol (2014) 0.86
Disruption of prostaglandin E2 receptor EP4 impairs urinary concentration via decreasing aquaporin 2 in renal collecting ducts. Proc Natl Acad Sci U S A (2015) 0.85
Stimulation of glucagon-like peptide-1 secretion by water loading in human. Dokl Biol Sci (2015) 0.84
Aquaporin-2: new mutations responsible for autosomal-recessive nephrogenic diabetes insipidus-update and epidemiology. Clin Kidney J (2012) 0.84
Purinergic signalling in the kidney in health and disease. Purinergic Signal (2013) 0.84
Primary molecular disorders and secondary biological adaptations in bartter syndrome. Int J Nephrol (2011) 0.82
Cell culture models and animal models for studying the patho-physiological role of renal aquaporins. Cell Mol Life Sci (2011) 0.82
Targeting renal purinergic signalling for the treatment of lithium-induced nephrogenic diabetes insipidus. Acta Physiol (Oxf) (2015) 0.81
Glycogen synthase kinase 3α regulates urine concentrating mechanism in mice. Am J Physiol Renal Physiol (2015) 0.81
A new theoretical approach to the functional meaning of sleep and dreaming in humans based on the maintenance of 'predictive psychic homeostasis'. Commun Integr Biol (2011) 0.79
Transcription Factor CREB3L1 Regulates Endoplasmic Reticulum Stress Response Genes in the Osmotically Challenged Rat Hypothalamus. PLoS One (2015) 0.79
Chronic use of chloroquine disrupts the urine concentration mechanism by lowering cAMP levels in the inner medulla. Am J Physiol Renal Physiol (2012) 0.78
Mechanisms of cell polarity and aquaporin sorting in the nephron. Pflugers Arch (2011) 0.78
Exenatide stimulates solute-free water clearance by the rat kidney in hyperhydration. Dokl Biol Sci (2011) 0.77
Heterologous downregulation of vasopressin type 2 receptor is induced by transferrin. Am J Physiol Renal Physiol (2012) 0.76
Transcription factor CREB3L1 mediates cAMP and glucocorticoid regulation of arginine vasopressin gene transcription in the rat hypothalamus. Mol Brain (2015) 0.76
PKCα regulates vasopressin-induced aquaporin-2 trafficking in mouse kidney collecting duct cells in vitro via altering microtubule assembly. Acta Pharmacol Sin (2012) 0.76
Spilanthol from Acmella Oleracea Lowers the Intracellular Levels of cAMP Impairing NKCC2 Phosphorylation and Water Channel AQP2 Membrane Expression in Mouse Kidney. PLoS One (2016) 0.76
Roflumilast and aquaporin-2 regulation in rat renal inner medullary collecting duct. Physiol Rep (2017) 0.75
Transcriptome analysis reveals manifold mechanisms of cyst development in ADPKD. Hum Genomics (2016) 0.75
A molecularly guided tour along the nephron. Pflugers Arch (2009) 0.75
Validation of an integrative mathematical model of dehydration and rehydration in virtual humans. Physiol Rep (2016) 0.75
Molecular mechanisms regulating aquaporin-2 in kidney collecting duct. Am J Physiol Renal Physiol (2016) 0.75
Lithium in kidney diseases: big roles for the smallest metal. J Am Soc Nephrol (2014) 0.75
Characterizing the reproductive transcriptomic correlates of acute dehydration in males in the desert-adapted rodent, Peromyscus eremicus. BMC Genomics (2017) 0.75
NDFIP allows NEDD4/NEDD4L-induced AQP2 ubiquitination and degradation. PLoS One (2017) 0.75
Receptors for purines and pyrimidines. Pharmacol Rev (1998) 13.92
Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat Genet (2003) 13.33
Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature (1998) 9.30
PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science (1996) 6.56
The polycystic kidney disease proteins, polycystin-1, polycystin-2, polaris, and cystin, are co-localized in renal cilia. J Am Soc Nephrol (2002) 5.58
The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat Genet (1995) 4.99
The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein. Nat Genet (2002) 4.54
Polycystin-2 is an intracellular calcium release channel. Nat Cell Biol (2002) 4.37
Vasopressin increases water permeability of kidney collecting duct by inducing translocation of aquaporin-CD water channels to plasma membrane. Proc Natl Acad Sci U S A (1995) 4.35
Cellular and subcellular immunolocalization of vasopressin-regulated water channel in rat kidney. Proc Natl Acad Sci U S A (1993) 3.82
The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways. Nature (2005) 3.82
Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist. Nat Med (2003) 3.78
PKD1 interacts with PKD2 through a probable coiled-coil domain. Nat Genet (1997) 3.58
Epac proteins: multi-purpose cAMP targets. Trends Biochem Sci (2006) 3.54
Myosin vb is associated with plasma membrane recycling systems. Mol Biol Cell (2001) 3.45
Quantitative phosphoproteomics of vasopressin-sensitive renal cells: regulation of aquaporin-2 phosphorylation at two sites. Proc Natl Acad Sci U S A (2006) 3.26
Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease. Nat Med (2004) 3.09
PKD1 induces p21(waf1) and regulation of the cell cycle via direct activation of the JAK-STAT signaling pathway in a process requiring PKD2. Cell (2002) 3.09
Homo- and heterodimeric interactions between the gene products of PKD1 and PKD2. Proc Natl Acad Sci U S A (1997) 3.06
Perinatal lethality with kidney and pancreas defects in mice with a targetted Pkd1 mutation. Nat Genet (1997) 3.06
Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat. J Am Soc Nephrol (2005) 2.92
Increased water intake decreases progression of polycystic kidney disease in the PCK rat. J Am Soc Nephrol (2006) 2.77
Identification and characterization of polycystin-2, the PKD2 gene product. J Biol Chem (1999) 2.74
Phosphorylation of serine 256 is required for cAMP-dependent regulatory exocytosis of the aquaporin-2 water channel. J Biol Chem (1997) 2.65
cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway. Kidney Int (2000) 2.65
Polycystin-2, the protein mutated in autosomal dominant polycystic kidney disease (ADPKD), is a Ca2+-permeable nonselective cation channel. Proc Natl Acad Sci U S A (2001) 2.62
Cellular and subcellular localization of the ARPKD protein; fibrocystin is expressed on primary cilia. Hum Mol Genet (2003) 2.55
Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells. Kidney Int (2004) 2.55
Phosphorylation and activation of a cAMP-specific phosphodiesterase by the cAMP-dependent protein kinase. Involvement of serine 54 in the enzyme activation. J Biol Chem (1996) 2.49
Cholangiocyte cilia detect changes in luminal fluid flow and transmit them into intracellular Ca2+ and cAMP signaling. Gastroenterology (2006) 2.43
Renal cystic diseases: a review. Adv Anat Pathol (2006) 2.27
Calcium restriction allows cAMP activation of the B-Raf/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype. J Biol Chem (2004) 2.26
Protein kinase A phosphorylation is involved in regulated exocytosis of aquaporin-2 in transfected LLC-PK1 cells. Am J Physiol (1997) 2.23
Polycystin 1 is required for the structural integrity of blood vessels. Proc Natl Acad Sci U S A (2000) 2.23
Cardiovascular, skeletal, and renal defects in mice with a targeted disruption of the Pkd1 gene. Proc Natl Acad Sci U S A (2001) 2.19
Collecting duct-specific knockout of the endothelin B receptor causes hypertension and sodium retention. Am J Physiol Renal Physiol (2006) 2.19
Epac-selective cAMP analog 8-pCPT-2'-O-Me-cAMP as a stimulus for Ca2+-induced Ca2+ release and exocytosis in pancreatic beta-cells. J Biol Chem (2002) 2.12
Loss of NFAT5 results in renal atrophy and lack of tonicity-responsive gene expression. Proc Natl Acad Sci U S A (2004) 2.12
Collecting duct-specific knockout of endothelin-1 alters vasopressin regulation of urine osmolality. Am J Physiol Renal Physiol (2005) 2.04
A-kinase anchoring proteins take shape. Curr Opin Cell Biol (2007) 2.03
Development of lithium-induced nephrogenic diabetes insipidus is dissociated from adenylyl cyclase activity. J Am Soc Nephrol (2006) 1.99
Dynamics of aquaporin-2 serine-261 phosphorylation in response to short-term vasopressin treatment in collecting duct. Am J Physiol Renal Physiol (2006) 1.96
Short-chain ubiquitination mediates the regulated endocytosis of the aquaporin-2 water channel. Proc Natl Acad Sci U S A (2006) 1.91
Calcineurin-NFATc signaling pathway regulates AQP2 expression in response to calcium signals and osmotic stress. Am J Physiol Cell Physiol (2006) 1.91
Defective aquaporin-2 trafficking in nephrogenic diabetes insipidus and correction by chemical chaperones. J Clin Invest (1998) 1.87
Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cells. J Am Soc Nephrol (2005) 1.87
The where's and when's of kinase anchoring. Trends Biochem Sci (2006) 1.83
Fibrocystin/polyductin, found in the same protein complex with polycystin-2, regulates calcium responses in kidney epithelia. Mol Cell Biol (2007) 1.81
Developmental expression of urine concentration-associated genes and their altered expression in murine infantile-type polycystic kidney disease. Dev Genet (1999) 1.80
Congenital progressive hydronephrosis (cph) is caused by an S256L mutation in aquaporin-2 that affects its phosphorylation and apical membrane accumulation. Proc Natl Acad Sci U S A (2006) 1.80
cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells. J Am Soc Nephrol (2000) 1.76
Regulation of aquaporin-2 trafficking by vasopressin in the renal collecting duct. Roles of ryanodine-sensitive Ca2+ stores and calmodulin. J Biol Chem (2000) 1.75
The role of putative phosphorylation sites in the targeting and shuttling of the aquaporin-2 water channel. J Biol Chem (2002) 1.69
Constitutive arrestin-mediated desensitization of a human vasopressin receptor mutant associated with nephrogenic diabetes insipidus. Proc Natl Acad Sci U S A (2001) 1.67
Cyclic-3',5'-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney. Kidney Int (1999) 1.66
Hypokalemia-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla and cortex. J Clin Invest (1996) 1.64
Lithium-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla. J Clin Invest (1995) 1.63
Antagonism of endogenous putative P2Y receptors reduces the growth of MDCK-derived cysts cultured in vitro. Am J Physiol Renal Physiol (2006) 1.63
A Role of myosin Vb and Rab11-FIP2 in the aquaporin-2 shuttle. Traffic (2006) 1.62
Late onset of renal and hepatic cysts in Pkd1-targeted heterozygotes. Nat Genet (1999) 1.61
A high-salt diet dissociates NO synthase-3 expression and NO production by the thick ascending limb. Hypertension (2005) 1.59
Apical extracellular calcium/polyvalent cation-sensing receptor regulates vasopressin-elicited water permeability in rat kidney inner medullary collecting duct. J Clin Invest (1997) 1.59
Nephrogenic diabetes insipidus. A V2 vasopressin receptor unable to stimulate adenylyl cyclase. J Biol Chem (1993) 1.55
The polycystic kidney disease-1 protein, polycystin-1, binds and activates heterotrimeric G-proteins in vitro. Biochem Biophys Res Commun (1998) 1.55
Neonatal mortality in an aquaporin-2 knock-in mouse model of recessive nephrogenic diabetes insipidus. J Biol Chem (2000) 1.55
Polycystic kidney disease: genes, proteins, animal models, disease mechanisms and therapeutic opportunities. J Intern Med (2007) 1.54
Severe urinary concentrating defect in renal collecting duct-selective AQP2 conditional-knockout mice. Proc Natl Acad Sci U S A (2006) 1.52
Nitric oxide and atrial natriuretic factor stimulate cGMP-dependent membrane insertion of aquaporin 2 in renal epithelial cells. J Clin Invest (2000) 1.50
Early embryonic renal tubules of wild-type and polycystic kidney disease kidneys respond to cAMP stimulation with cystic fibrosis transmembrane conductance regulator/Na(+),K(+),2Cl(-) Co-transporter-dependent cystic dilation. J Am Soc Nephrol (2006) 1.50
Inhibition of endocytosis causes phosphorylation (S256)-independent plasma membrane accumulation of AQP2. Am J Physiol Renal Physiol (2003) 1.50
Collecting duct-specific knockout of the endothelin A receptor alters renal vasopressin responsiveness, but not sodium excretion or blood pressure. Am J Physiol Renal Physiol (2005) 1.49
Lack of arginine vasopressin-induced phosphorylation of aquaporin-2 mutant AQP2-R254L explains dominant nephrogenic diabetes insipidus. J Am Soc Nephrol (2005) 1.49
Molecular physiology of urinary concentrating mechanism: regulation of aquaporin water channels by vasopressin. Am J Physiol (1997) 1.48
Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus. Am J Physiol Renal Physiol (2006) 1.48
PKA-phosphorylation of PDE4D3 facilitates recruitment of the mAKAP signalling complex. Biochem J (2004) 1.47
Comparative analysis of the polycystic kidney disease 1 (PKD1) gene reveals an integral membrane glycoprotein with multiple evolutionary conserved domains. Hum Mol Genet (1997) 1.45
An aquaporin-2 water channel mutant which causes autosomal dominant nephrogenic diabetes insipidus is retained in the Golgi complex. J Clin Invest (1998) 1.45
The subcellular localization of an aquaporin-2 tetramer depends on the stoichiometry of phosphorylated and nonphosphorylated monomers. J Cell Biol (2000) 1.44
Kinesin-2 mediates physical and functional interactions between polycystin-2 and fibrocystin. Hum Mol Genet (2006) 1.43
G protein-coupled prostanoid receptors and the kidney. Annu Rev Physiol (2001) 1.43
Adenylate cyclase-coupled vasopressin receptor activates AQP2 promoter via a dual effect on CRE and AP1 elements. Am J Physiol (1997) 1.42
Extracellular nucleotide signaling along the renal epithelium. Am J Physiol Renal Physiol (2001) 1.42
Polycystin-1, the PKD1 gene product, is in a complex containing E-cadherin and the catenins. J Clin Invest (1999) 1.41
Calmodulin is required for vasopressin-stimulated increase in cyclic AMP production in inner medullary collecting duct. J Biol Chem (2005) 1.40
Prostaglandin E2 inhibits sodium transport in rabbit cortical collecting duct by increasing intracellular calcium. J Clin Invest (1991) 1.39
Identification of a novel A-kinase anchoring protein 18 isoform and evidence for its role in the vasopressin-induced aquaporin-2 shuttle in renal principal cells. J Biol Chem (2004) 1.39
Antidiuretic action of vasopressin: quantitative aspects and interaction between V1a and V2 receptor-mediated effects. Cardiovasc Res (2001) 1.37
Aquaporin-2 localization in clathrin-coated pits: inhibition of endocytosis by dominant-negative dynamin. Am J Physiol Renal Physiol (2002) 1.36
cAMP sensor Epac as a determinant of ATP-sensitive potassium channel activity in human pancreatic beta cells and rat INS-1 cells. J Physiol (2006) 1.36
Bidirectional regulation of AQP2 trafficking and recycling: involvement of AQP2-S256 phosphorylation. Am J Physiol Renal Physiol (2004) 1.35
Heat shock protein 70 interacts with aquaporin-2 and regulates its trafficking. J Biol Chem (2007) 1.35
Calcium: a fundamental regulator of intracellular membrane fusion? EMBO Rep (2007) 1.32
Water channels encoded by mutant aquaporin-2 genes in nephrogenic diabetes insipidus are impaired in their cellular routing. J Clin Invest (1995) 1.32
Osmoreceptors, osmoreception, and osmoregulation. Front Neuroendocrinol (1994) 1.32
An impaired routing of wild-type aquaporin-2 after tetramerization with an aquaporin-2 mutant explains dominant nephrogenic diabetes insipidus. EMBO J (1999) 1.31
Purinergic signaling along the renal tubule: the current state of play. News Physiol Sci (2003) 1.29
Tonicity-responsive enhancer binding protein is an essential regulator of aquaporin-2 expression in renal collecting duct principal cells. J Am Soc Nephrol (2006) 1.28
The cystic fibrosis transmembrane conductance regulator mediates transepithelial fluid secretion by human autosomal dominant polycystic kidney disease epithelium in vitro. Kidney Int (1996) 1.28
Polycystin-1 activates the calcineurin/NFAT (nuclear factor of activated T-cells) signaling pathway. J Biol Chem (2004) 1.26
Changes in cellular composition of kidney collecting duct cells in rats with lithium-induced NDI. Am J Physiol Cell Physiol (2003) 1.26
Desmopressin for nocturnal enuresis in nephrogenic diabetes insipidus. Lancet (2002) 2.10
Development of lithium-induced nephrogenic diabetes insipidus is dissociated from adenylyl cyclase activity. J Am Soc Nephrol (2006) 1.99
Short-chain ubiquitination mediates the regulated endocytosis of the aquaporin-2 water channel. Proc Natl Acad Sci U S A (2006) 1.91
The role of putative phosphorylation sites in the targeting and shuttling of the aquaporin-2 water channel. J Biol Chem (2002) 1.69
Lack of arginine vasopressin-induced phosphorylation of aquaporin-2 mutant AQP2-R254L explains dominant nephrogenic diabetes insipidus. J Am Soc Nephrol (2005) 1.49
Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus. Am J Physiol Renal Physiol (2006) 1.48
Quaternary ammonium compounds as water channel blockers. Specificity, potency, and site of action. J Biol Chem (2006) 1.46
Small-molecule screening identifies modulators of aquaporin-2 trafficking. J Am Soc Nephrol (2013) 1.41
Glycosylation is important for cell surface expression of the water channel aquaporin-2 but is not essential for tetramerization in the endoplasmic reticulum. J Biol Chem (2003) 1.32
Lithium causes G2 arrest of renal principal cells. J Am Soc Nephrol (2014) 1.26
RasGRP1 stimulation enhances ubiquitination and endocytosis of the sodium-chloride cotransporter. Am J Physiol Renal Physiol (2010) 1.20
Heteroligomerization of an Aquaporin-2 mutant with wild-type Aquaporin-2 and their misrouting to late endosomes/lysosomes explains dominant nephrogenic diabetes insipidus. Hum Mol Genet (2002) 1.18
Aquaporin 2 mutations in nephrogenic diabetes insipidus. Semin Nephrol (2008) 1.15
MAL decreases the internalization of the aquaporin-2 water channel. Proc Natl Acad Sci U S A (2007) 1.14
Amiloride blocks lithium entry through the sodium channel thereby attenuating the resultant nephrogenic diabetes insipidus. Kidney Int (2009) 1.11
Regulation of AQP2 localization by S256 and S261 phosphorylation and ubiquitination. Am J Physiol Cell Physiol (2010) 1.10
Marine fish egg hydration is aquaporin-mediated. Science (2005) 1.09
Localization of the succinate receptor in the distal nephron and its signaling in polarized MDCK cells. Kidney Int (2009) 1.08
Yolk proteolysis and aquaporin-1o play essential roles to regulate fish oocyte hydration during meiosis resumption. Dev Biol (2006) 1.07
Cell-biologic and functional analyses of five new Aquaporin-2 missense mutations that cause recessive nephrogenic diabetes insipidus. J Am Soc Nephrol (2002) 1.06
Reversed polarized delivery of an aquaporin-2 mutant causes dominant nephrogenic diabetes insipidus. J Cell Biol (2003) 1.05
SLC29A3 gene is mutated in pigmented hypertrichosis with insulin-dependent diabetes mellitus syndrome and interacts with the insulin signaling pathway. Hum Mol Genet (2009) 1.05
Congenital nephrogenic diabetes insipidus: the current state of affairs. Pediatr Nephrol (2012) 1.04
Role of cytoplasmic termini in sorting and shuttling of the aquaporin-2 water channel. Am J Physiol Cell Physiol (2003) 1.03
CO2 permeability of cell membranes is regulated by membrane cholesterol and protein gas channels. FASEB J (2012) 1.02
Hypertonicity is involved in redirecting the aquaporin-2 water channel into the basolateral, instead of the apical, plasma membrane of renal epithelial cells. J Biol Chem (2002) 1.01
Autosomal recessive mental retardation, deafness, ankylosis, and mild hypophosphatemia associated with a novel ANKH mutation in a consanguineous family. J Clin Endocrinol Metab (2010) 1.00
alphaENaC-mediated lithium absorption promotes nephrogenic diabetes insipidus. J Am Soc Nephrol (2010) 0.99
Intracellular activation of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus by nonpeptide agonists. Proc Natl Acad Sci U S A (2009) 0.96
Renal expression of exchange protein directly activated by cAMP (Epac) 1 and 2. Am J Physiol Renal Physiol (2008) 0.95
LIP5 interacts with aquaporin 2 and facilitates its lysosomal degradation. J Am Soc Nephrol (2009) 0.94
In mpkCCD cells, long-term regulation of aquaporin-2 by vasopressin occurs independent of protein kinase A and CREB but may involve Epac. Am J Physiol Renal Physiol (2012) 0.94
X-ray structure of human aquaporin 2 and its implications for nephrogenic diabetes insipidus and trafficking. Proc Natl Acad Sci U S A (2014) 0.94
Nucleotides downregulate aquaporin 2 via activation of apical P2 receptors. J Am Soc Nephrol (2009) 0.93
Genetic analysis of mouse strains with variable serum sodium concentrations identifies the Nalcn sodium channel as a novel player in osmoregulation. Physiol Genomics (2010) 0.92
A novel mechanism in recessive nephrogenic diabetes insipidus: wild-type aquaporin-2 rescues the apical membrane expression of intracellularly retained AQP2-P262L. Hum Mol Genet (2004) 0.89
Lithium reduces aquaporin-2 transcription independent of prostaglandins. Am J Physiol Cell Physiol (2011) 0.87
Thiazide-induced hyponatraemia is associated with increased water intake and impaired urea-mediated water excretion at low plasma antidiuretic hormone and urine aquaporin-2. J Hypertens (2015) 0.86
Counteracting vasopressin-mediated water reabsorption by ATP, dopamine, and phorbol esters: mechanisms of action. Am J Physiol Renal Physiol (2011) 0.84
Polarisation, key to good localisation. Biochim Biophys Acta (2006) 0.84
Intellectual disability and bleeding diathesis due to deficient CMP--sialic acid transport. Neurology (2013) 0.84
Hydrochlorothiazide attenuates lithium-induced nephrogenic diabetes insipidus independently of the sodium-chloride cotransporter. Am J Physiol Renal Physiol (2013) 0.83
Pharmacological chaperones in nephrogenic diabetes insipidus: possibilities for clinical application. BioDrugs (2007) 0.83
Vasopressin increases S261 phosphorylation in AQP2-P262L, a mutant in recessive nephrogenic diabetes insipidus. Nephrol Dial Transplant (2012) 0.83
p.R254Q mutation in the aquaporin-2 water channel causing dominant nephrogenic diabetes insipidus is due to a lack of arginine vasopressin-induced phosphorylation. Hum Mutat (2009) 0.82
Effect of the cGMP pathway on AQP2 expression and translocation: potential implications for nephrogenic diabetes insipidus. Nephrol Dial Transplant (2009) 0.81
Characterization of an aquaporin-2 water channel gene mutation causing partial nephrogenic diabetes insipidus in a Mexican family: evidence of increased frequency of the mutation in the town of origin. J Am Soc Nephrol (2004) 0.81
The physiological implication of novel proteins in systemic osmoregulation. FASEB J (2011) 0.80
Congenital nephrogenic diabetes insipidus: what can we learn from mouse models? Exp Physiol (2008) 0.80
Novel mutation in the AVPR2 gene in a Danish male with nephrogenic diabetes insipidus caused by ER retention and subsequent lysosomal degradation of the mutant receptor. NDT Plus (2011) 0.78
Hypotonicity-induced reduction of aquaporin-2 transcription in mpkCCD cells is independent of the tonicity responsive element, vasopressin, and cAMP. J Biol Chem (2011) 0.77
Repulsion between Lys258 and upstream arginines explains the missorting of the AQP2 mutant p.Glu258Lys in nephrogenic diabetes insipidus. Hum Mutat (2009) 0.77
Missorting of the Aquaporin-2 mutant E258K to multivesicular bodies/lysosomes in dominant NDI is associated with its monoubiquitination and increased phosphorylation by PKC but is due to the loss of E258. Pflugers Arch (2007) 0.76
Blockade of dopamine, but not noradrenaline, transporters produces hyperthermia in rats that lack serotonin transporters. Eur J Pharmacol (2009) 0.76
A systems biology approach: modelling of Aquaporin-2 trafficking. Genome Inform (2010) 0.76
The lysosomal trafficking regulator interacting protein-5 localizes mainly in epithelial cells. J Mol Histol (2010) 0.76
Demeclocycline attenuates hyponatremia by reducing aquaporin-2 expression in the renal inner medulla. Am J Physiol Renal Physiol (2013) 0.75